Publikationen, an denen er mitarbeitet LUIS FCO GRANERO MACIA (20)

2023

  1. The rostromedial tegmental nucleus RMTg is not a critical site for ethanol-induced motor activation in rats

    Psychopharmacology, Vol. 240, Núm. 10, pp. 2071-2080

2022

  1. Different brain oxidative and neuroinflammation status in rats during prolonged abstinence depending on their ethanol relapse-like drinking behavior: Effects of ethanol reintroduction

    Drug and Alcohol Dependence, Vol. 232

2021

  1. Efficacy of N-acetylcysteine in the prevention of alcohol relapse-like drinking: Study in long-term ethanol-experienced male rats

    Journal of Neuroscience Research, Vol. 99, Núm. 2, pp. 638-648

  2. The effects of N-acetylcysteine on the rat mesocorticolimbic pathway: Role of MGluR5 receptors and interaction with ethanol

    Pharmaceuticals, Vol. 14, Núm. 6

2017

  1. Pre-clinical studies with d-penicillamine as a novel pharmacological strategy to treat alcoholism: Updated evidences

    Frontiers in Behavioral Neuroscience, Vol. 11

  2. Regional differences in mu-opioid receptor-dependent modulation of basal dopamine transmission in rat striatum

    Neuroscience Letters, Vol. 638, pp. 102-108

2014

  1. Disposition of D-penicillamine, a promising drug for preventing alcohol-relapse. Influence of dose, chronic alcohol consumption and age: Studies in rats

    Biopharmaceutics and Drug Disposition, Vol. 35, Núm. 5, pp. 284-295

  2. Improved effect of the combination naltrexone/D-penicillamine in the prevention of alcohol relapse-like drinking in rats

    Journal of Psychopharmacology, Vol. 28, Núm. 1, pp. 76-81

2013

  1. Quantitative in vivo microdialysis in pharmacokinetic studies

    Neuromethods, Vol. 75, pp. 103-120

2006

  1. Evidence of a flip-flop phenomenon in acamprosate pharmacokinetics: An in vivo study in rats

    Biopharmaceutics and Drug Disposition, Vol. 27, Núm. 7, pp. 305-311

2005

  1. Hippocampal dopamine receptors modulate cFos expression in the rat nucleus accumbens evoked by chemical stimulation of the ventral hippocampus

    Neuropharmacology, Vol. 49, Núm. 7, pp. 1067-1076

  2. Hippocampal dopamine receptors modulate the motor activation and the increase in dopamine levels in the rat nucleus accumbens evoked by chemical stimulation of the ventral hippocampus

    Neuropsychopharmacology, Vol. 30, Núm. 5, pp. 843-852

  3. Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: A target for drug delivery

    Current Drug Delivery, Vol. 2, Núm. 1, pp. 9-22

  4. Quantitative in vivo microdialysis in pharmacokinetic studies: Some reminders

    Current Drug Metabolism, Vol. 6, Núm. 2, pp. 83-90

2004

  1. Assessment and modulation of acamprosate intestinal absorption: Comparative studies using in situ, in vitro (CACO-2 cell monolayers) and in vivo models

    European Journal of Pharmaceutical Sciences, Vol. 22, Núm. 5, pp. 347-356

2003

  1. Acamprosate blocks the increase in dopamine extracellular levels in nucleus accumbens evoked by chemical stimulation of the ventral hippocampus

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 368, Núm. 4, pp. 324-327

  2. Influencia del caprato sódico en l absorción intestinal del acamprosato en CACO-2

    VI Congreso de la Sociedad Española de Farmacia Industrial y Galénica. 3ª Jornadas de Tecnología Farmecéutica. Granada, 9-11 de febrero de 2003.: Libro de Comunicaciones (Comares), pp. 425-426

  3. Local acamprosate modulates dopamine release in the rat nucleus accumbens through NMDA receptors: An in vivo microdialysis study

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 367, Núm. 2, pp. 119-125

  4. Pharmacology of Acamprosate: An Overview

    CNS Drug Reviews, Vol. 9, Núm. 4, pp. 359-374

2002

  1. Quitosanos: Usos y aplicaciones en tecnología farmacéutica

    Ciencia y Tecnologia Pharmaceutica, Vol. 12, Núm. 4, pp. 180-189